RETRACTED: MicroRNA-34a alleviates steroid-induced avascular necrosis of femoral head by targeting Tgif2 through OPG/RANK/RANKL signaling pathway

Abstract

Keywords

MiR-34a steroid-induced avascular necrosis of femoral head osteoprotegerin receptor activator of nuclear factor Kappa B receptor activator of nuclear factor Kappa ligand signaling pathway

Get full access to this article

View all access options for this article.

References

Zhang

Zou

Dang

Wang

. Apoptosis associated with wnt/beta-catenin pathway leads to steroid-induced avascular necrosis of femoral head. BMC Musculoskelet Disord 2015; 16: 132–132.

Erken

Ofluoglu

Aktas

Topal

Yildiz

. Effect of pentoxifylline on histopathological changes in steroid-induced osteonecrosis of femoral head: experimental study in chicken. Int Orthop 2012; 36: 1523–8.

Kaushik

Das

Cui

. Osteonecrosis of the femoral head: an update in year 2012. World J Orthop 2012; 3: 49–57.

Lee

Kang

Lee

Kim

Song

Koo

. Vascular endothelial growth factor polymorphisms in patients with steroid-induced femoral head osteonecrosis. J Orthop Res 2012; 30: 21–7.

Ney

Fehm

Juhasz-Boess

Solomayer

. Rank, rankl and opg expression in breast cancer - influence on osseous metastasis. Geburtshilfe Frauenheilkd 2012; 72: 385–91.

Song

Wei

Xie

Zhang

Wang

. Effects of wenyangbushen formula on the expression of vegf, opg, rank and rankl in rabbits with steroid-induced femoral head avascular necrosis. Mol Med Rep 2015; 12: 8155–61.

Papaioannou

Mirzamohammadi

Kobayashi

. Micrornas involved in bone formation. Cell Mol Life Sci 2014; 71: 4747–61.

Cui

Lin

. Microrna-34a inhibits tumor invasion and metastasis in gastric cancer by targeting tgif2. Int J Clin Exp Pathol 2015; 8: 8921–8.

Krzeszinski

Wei

Huynh

Jin

Wang

Chang

Xie

Mangala

Lopez-Berestein

Sood

Mendell

Wan

. Mir-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and tgif2. Nature 2014; 512: 431–5.

10.

Wei

Shi

Zheng

Zhou

Inose

Wang

Guo

Grosschedl

Karsenty

. Mir-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting satb2. J Cell Biol 2012; 197: 509–21.

11.

Hadjidakis

Androulakis

. Bone remodeling. Ann N Y Acad Sci 2006; 1092: 385–96.

12.

Roshandel

Holliday

Pye

Boonen

Borghs

Vanderschueren

Huhtaniemi

Adams

Ward

Bartfai

Casanueva

Finn

Forti

Giwercman

Han

Kula

Lean

Pendleton

Punab

Silman

Thomson

O'Neill

Group

. Genetic variation in the rankl/rank/opg signaling pathway is associated with bone turnover and bone mineral density in men. J Bone Miner Res 2010; 25: 1830–8.

13.

Lopes

Ferraz

Almeida

Florio

Gimenes

Rosa

Beloti

. Participation of microrna-34a and rankl on bone repair induced by poly(vinylidene-trifluoroethylene)/barium titanate membrane. J Biomater Sci Polym Ed 2016; 27: 1369–79.

14.

Martin

Sims

. Rankl/opg; critical role in bone physiology. Rev Endocr Metab Disord 2015; 16: 131–9.

15.

Tanaka

. Signaling axis in osteoclast biology and therapeutic targeting in the rankl/rank/opg system. Am J Nephrol 2007; 27: 466–78.

16.

Chen

Sosnoski

Mastro

. Breast cancer metastasis to the bone: mechanisms of bone loss. Breast Cancer Res 2010; 12: 215–215.

17.

Wang

Jiang

Fan

Zhang

Sun

Zhang

Liu

. Microrna-34c targets tgfb-induced factor homeobox 2, represses cell proliferation and induces apoptosis in hepatitis b virus-related hepatocellular carcinoma. Oncol Lett 2015; 10: 3095–102.

18.

Todenhofer

Hennenlotter

Schmiedel

Hohneder

Grimm

Kuhs

Salih

Buhring

Fehm

Gakis

Blumenstock

Aufderklamm

Schilling

Stenzl

Schwentner

. Alterations of the rankl pathway in blood and bone marrow samples of prostate cancer patients without bone metastases. Prostate 2013; 73: 162–8.

19.

Santini

Perrone

Roato

Godio

Pantano

Grasso

Russo

Vincenzi

Fratto

Sabbatini

Della Pepa

Porta

Del Conte

Schiavon

Berruti

Tomasino

Papotti

Papapietro

Onetti Muda

Denaro

Tonini

. Expression pattern of receptor activator of nfkappab (rank) in a series of primary solid tumors and related bone metastases. J Cell Physiol 2011; 226: 780–4.

20.

Wittrant

Theoleyre

Chipoy

Padrines

Blanchard

Heymann

Redini

. Rankl/rank/opg: New therapeutic targets in bone tumours and associated osteolysis. Biochim Biophys Acta 2004; 1704: 49–57.

21.

Tinoco

Dias

Dall'Astta

Pamphile

Aragao

. In vivo trans-specific gene silencing in fungal cells by in planta expression of a double-stranded rna. BMC Biol 2010; 8: 27–27.

22.

Bonjour

. Calcium and phosphate: a duet of ions playing for bone health. J Am Coll Nutr 2011; 30: 438S–48.

23.

Lems

. Fracture risk estimation may facilitate the treatment gap in osteoporosis. Ann Rheum Dis 2015; 74: 1943–5.

24.

Chmielnicka

Wozniacka

Torzecka

. The influence of corticosteroid treatment on the opg/rank/rankl pathway and osteocalcin in patients with pemphigus. Postepy Dermatol Alergol 2014; 31: 281–8.

25.

Komori

. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res 2010; 339: 189–95.

26.

Fan

Jia

Zheng

Jin

Liu

Zhou

. MiR-34a Promotes osteogenic differentiation of human adipose-derived stem cells via the RBP2/NOTCH1/CYCLIN D1 coregulatory network. Stem Cell Rep 2016; 7: 236–48.

27.

Saito

Nakatomi

Ida-Yonemochi

Ohshima

. Osteopontin is essential for type I collagen secretion in reparative dentin. J Dent Res 2016; 95: 1034–41.

28.

Minenna

D'Amore

Maggiolini

Scagliusi

D'Amore

. [RANKL/RANK, OPG and OPT in a group of patients affected by chronic arthritis. Preliminary report]. Recenti Prog Med 2005; 96: 431–2.

29.

Chmielnicka

Wozniacka

Torzecka

. The influence of corticosteroid treatment on the OPG/RANK/RANKL pathway and osteocalcin in patients with pemphigus. Postepy Dermatol Alergol 2014; 31: 281–8.

30.

Kanazawa

Yamaguchi

Yamamoto

Yamauchi

Kurioka

Yano

Sugimoto

. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009; 94: 45–9.

31.

Tamura

Uyama

Sugiyama

Sato

. Canonical Wnt signaling activates miR-34 expression during osteoblastic differentiation. Mol Med Rep 2013; 8: 1807–11.